Agrify CorporationPlacement Agent Agreement • February 28th, 2024 • Agrify Corp • Agricultural services • New York
Contract Type FiledFebruary 28th, 2024 Company Industry Jurisdiction
Agrify CorporationPlacement Agent Agreement • February 14th, 2024 • Agrify Corp • Agricultural services • New York
Contract Type FiledFebruary 14th, 2024 Company Industry Jurisdiction
Agrify CorporationPlacement Agent Agreement • February 8th, 2024 • Agrify Corp • Agricultural services • New York
Contract Type FiledFebruary 8th, 2024 Company Industry Jurisdiction
Adamis Pharmaceuticals Corporation 8-KPlacement Agent Agreement • August 3rd, 2023 • Adamis Pharmaceuticals Corp • Pharmaceutical preparations • New York
Contract Type FiledAugust 3rd, 2023 Company Industry JurisdictionThis letter (the “Agreement”) constitutes the agreement between Maxim Group LLC (the “Placement Agent”) and Adamis Pharmaceuticals Corporation, a Delaware corporation (the “Company”), that the Placement Agent shall serve as the exclusive placement agent for the Company, on a “reasonable best efforts” basis, in connection with the proposed placement (the “Placement”) to certain purchasers (the “Purchasers”) of up to an aggregate of (i) 4,800,000 common units (each a “Common Unit” and collectively, the “Common Units”), with each Common Unit consisting of (A) one share (each a “Share” and collectively, the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), (B) one common stock purchase warrant (each a “Warrant” and collectively, the “Warrants”) to purchase one share of Common Stock (the “Warrant Shares”) exercisable immediately and expiring five years after the date of issuance at an exercise price of $1.35 per share of Common Stock, and (ii) 1,130,
Adamis Pharmaceuticals Corporation S-1Placement Agent Agreement • July 13th, 2023 • Adamis Pharmaceuticals Corp • Pharmaceutical preparations • New York
Contract Type FiledJuly 13th, 2023 Company Industry JurisdictionThis letter (the “Agreement”) constitutes the agreement between Maxim Group LLC (the “Placement Agent”) and Adamis Pharmaceuticals Corporation, a Delaware corporation (the “Company”), that the Placement Agent shall serve as the exclusive placement agent for the Company, on a “reasonable best efforts” basis, in connection with the proposed placement (the “Placement”) to certain purchasers (the “Purchasers”) of up to an aggregate of (i) [___] common units (each a “Common Unit” and collectively, the “Common Units”), with each Common Unit consisting of (A) one share (each a “Share” and collectively, the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), (B) one common stock purchase warrant (each a “Warrant” and collectively, the “Warrants”) to purchase one share of Common Stock (the “Warrant Shares”) exercisable immediately and expiring five years after the date of issuance at an exercise price of $[__] per share of Common Stock, and (ii) [____] pre